FDA issued a Warning Letter to BioReliance Corporation on 1/5/2009 for a previous inspection.
483 BioReliance Feb 2011

483 BioReliance Feb 2011

Cynthia Harris FDA$119.00 - Available Now

FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued 5 inspectional observations (via FDA 483) on 04 Feb 2011.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 04 Feb 2011
  • Location: Rockville, United States
  • FEI: 1122041
Add To Cart